Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
Duarte
Ana Filipa
AF
Correia
Osvaldo
O
Azevedo
Rosa
R
do Carmo Palmares
Maria
M
Delgado
Luís
L
D000368:Aged; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000077613:Etoricoxib; D006801:Humans; D008297:Male; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000378:metabolism; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects*
D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib